Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives
Natalia G. Vallianou, Theodora Stratigou, Gerasimos Socrates Christodoulatos, et al.
Current Obesity Reports (2020) Vol. 9, Iss. 3, pp. 179-192
Closed Access | Times Cited: 171

Showing 1-25 of 171 citing articles:

A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh Esfehani, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 1
Open Access | Times Cited: 307
Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 573-599
Open Access | Times Cited: 288
Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review
Hangyu Li, Dan-Dan Zhou, Ren‐You Gan, et al.
Nutrients (2021) Vol. 13, Iss. 9, pp. 3211-3211
Open Access | Times Cited: 274
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
Natalia G. Vallianou, Gerasimos Socrates Christodoulatos, Ιrene Karampela, et al.
Biomolecules (2021) Vol. 12, Iss. 1, pp. 56-56
Open Access | Times Cited: 176
Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility
Valeria Calcaterra, Elvira Verduci, Hellas Cena, et al.
Nutrients (2021) Vol. 13, Iss. 6, pp. 1848-1848
Open Access | Times Cited: 134
Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics
Dan Li, Yujuan Li, Shengjie Yang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113290-113290
Open Access | Times Cited: 89
Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota
Ashwinipriyadarshini Megur, Eric Banan-Mwine Daliri, Daiva Baltriukienė, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6097-6097
Open Access | Times Cited: 80
Emerging Technologies and Coating Materials for Improved Probiotication in Food Products: a Review
Sourav Misra, Pooja Pandey, Chandrakant Genu Dalbhagat, et al.
Food and Bioprocess Technology (2022) Vol. 15, Iss. 5, pp. 998-1039
Open Access | Times Cited: 77
The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
Natalia G. Vallianou, Dimitris Kounatidis, Dimitrios Tsilingiris, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6755-6755
Open Access | Times Cited: 61
Blastocystis: A Mysterious Member of the Gut Microbiome
Mehmet Aykur, Erdoğan Malatyalı, Filiz Demirel, et al.
Microorganisms (2024) Vol. 12, Iss. 3, pp. 461-461
Open Access | Times Cited: 25
NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment Options
Natalia G. Vallianou, Dimitris Kounatidis, Sotiria Psallida, et al.
Metabolites (2024) Vol. 14, Iss. 7, pp. 366-366
Open Access | Times Cited: 20
Extracellular vesicles and pasteurized cells derived from Akkermansia muciniphila protect against high-fat induced obesity in mice
Fatemeh Ashrafian, Shahrbanoo Keshavarz Azizi Raftar, Arezou Lari, et al.
Microbial Cell Factories (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Probiotics supplementation and insulin resistance: a systematic review
Bárbara Izabel Moraes Salles, Débora Cioffi, Sandra Roberta G. Ferreira
Diabetology & Metabolic Syndrome (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 73
Do Antibiotics Cause Obesity Through Long-term Alterations in the Gut Microbiome? A Review of Current Evidence
Natalia G. Vallianou, Μaria Dalamaga, Theodora Stratigou, et al.
Current Obesity Reports (2021) Vol. 10, Iss. 3, pp. 244-262
Open Access | Times Cited: 73
The clinical evidence for postbiotics as microbial therapeutics
Alexis Mosca, A.T. Abreu y Abreu, Kok‐Ann Gwee, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 66
Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial
Audrey M. Neyrinck, Julie Rodriguez, Zhengxiao Zhang, et al.
European Journal of Nutrition (2021) Vol. 60, Iss. 6, pp. 3159-3170
Open Access | Times Cited: 64
Understanding the Co-Epidemic of Obesity and COVID-19: Current Evidence, Comparison with Previous Epidemics, Mechanisms, and Preventive and Therapeutic Perspectives
Μaria Dalamaga, Gerasimos Socrates Christodoulatos, Ιrene Karampela, et al.
Current Obesity Reports (2021) Vol. 10, Iss. 3, pp. 214-243
Open Access | Times Cited: 64
Mycobiome and Cancer: What Is the Evidence?
Natalia G. Vallianou, Dimitris Kounatidis, Gerasimos Socrates Christodoulatos, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3149-3149
Open Access | Times Cited: 63
The future of functional food: Emerging technologies application on prebiotics, probiotics and postbiotics
Celso F. Balthazar, Jonas F. Guimarães, Nathália M. Coutinho, et al.
Comprehensive Reviews in Food Science and Food Safety (2022) Vol. 21, Iss. 3, pp. 2560-2586
Closed Access | Times Cited: 63
From Pre- and Probiotics to Post-Biotics: A Narrative Review
Emidio Scarpellini, Emanuele Rinninella, Martina Basilico, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 19, Iss. 1, pp. 37-37
Open Access | Times Cited: 55
The Effects of Probiotics on Inflammation, Endothelial Dysfunction, and Atherosclerosis Progression: A Mechanistic Overview
Marjan Mahdavi‐Roshan, Arsalan Salari, Jalal Kheirkhah, et al.
Heart Lung and Circulation (2022) Vol. 31, Iss. 5, pp. e45-e71
Closed Access | Times Cited: 39
The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials
Pradipta Paul, Ridhima Kaul, Manale Harfouche, et al.
Pharmacological Research (2022) Vol. 185, pp. 106520-106520
Open Access | Times Cited: 39
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies
Gianluca Quaranta, Alessandra Guarnaccia, Giovanni Fancello, et al.
Microorganisms (2022) Vol. 10, Iss. 12, pp. 2424-2424
Open Access | Times Cited: 38
Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy
Carlo Airola, Andrea Severino, Serena Porcari, et al.
Antibiotics (2023) Vol. 12, Iss. 5, pp. 868-868
Open Access | Times Cited: 27
Beneficial Bacteria Isolated from Food in Relation to the Next Generation of Probiotics
Barbara Sionek, Aleksandra Szydłowska, Dorota Zielińska, et al.
Microorganisms (2023) Vol. 11, Iss. 7, pp. 1714-1714
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top